P455 Improvement of ulcerative-colitis-associated microbiota dysbiosis after treatment with mesalazine-MMX (Mezavant®) using mucosal Faecalobacterium prausnitzii/Escherichia coli index as a marker
Autor: | Miquel Cusachs, J.O., Busquets Casals, D., Serra-Pages, M., Garcia-Gil, J., Aldeguer Manté, X. |
---|---|
Zdroj: | In Journal of Crohn's and Colitis February 2014 8 Supplement 1:S255-S256 |
Databáze: | ScienceDirect |
Externí odkaz: |